Anti-CHSY2, C-Terminal antibody produced in rabbit

Name	Anti-CHSY2, C-Terminal antibody produced in rabbit
Supplier	Sigma-Aldrich
Catalog	SAB4503161
Prices	$335.50
Sizes	100 µg
Host	Rabbit
Clonality	Polyclonal
Applications	IHC WB
Species Reactivities	Rat, Human, Mouse
Antigen	Synthesized peptide derived from human CHSY2
Description	Rabbit Polyclonal
Gene	CHPF
Conjugate	unconjugated
Supplier Page	Shop

Product images

<B>Immunohistochemistry</B><BR/>CHSY2 Antibody: <B>Cat. No. SAB4503161</B>: Immunohistochemistry analysis of paraffin-embedded human cervix carcinoma tissue, using CHSY2 Antibody. The picture on the right is treated with the synthesized peptide.

Immunohistochemistry
CHSY2 Antibody: Cat. No. SAB4503161: Immunohistochemistry analysis of paraffin-embedded human cervix carcinoma tissue, using CHSY2 Antibody. The picture on the right is treated with the synthesized peptide.

<B>Immunofluorescence</B><BR/>Anti-CHSY2: <B>Cat. No. SAB4503161</B>: Immunofluorescence of MCF7 cells using Anti-CHSY2 antibody. Cells on the left were treated with the Anti-CHSY2 antibody. Cells on the right (negative control) were treated with both Anti-CHSY2 antibody and the synthesized immunogen peptide.

Immunofluorescence
Anti-CHSY2: Cat. No. SAB4503161: Immunofluorescence of MCF7 cells using Anti-CHSY2 antibody. Cells on the left were treated with the Anti-CHSY2 antibody. Cells on the right (negative control) were treated with both Anti-CHSY2 antibody and the synthesized immunogen peptide.

<B>Immunoblotting</B><BR/>Anti-CHSY2: <B>Cat. No. SAB4503161</B>: Immunoblotting analysis of extracts from LOVO/K562 cells, using Anti-CHSY2 antibody. The lane on the left was treated with the Anti-CHSY2 antibody. The lane on the right (negative control) was treated with both Anti-CHSY2 antibody and the synthesized immunogen peptide.

Immunoblotting
Anti-CHSY2: Cat. No. SAB4503161: Immunoblotting analysis of extracts from LOVO/K562 cells, using Anti-CHSY2 antibody. The lane on the left was treated with the Anti-CHSY2 antibody. The lane on the right (negative control) was treated with both Anti-CHSY2 antibody and the synthesized immunogen peptide.